Back to results
US 12,006,358 B2Granted
Antibody against advanced glycation end products and use thereof
AssigneeBloom Technology, Inc.
InventorsTetsuro Yamamoto, Shota Tsuchida, Tomoaki Shigeta, Kazumi Sasamoto, Mami Chirifu
Life of this patent
Estimating the term…
Abstract
The present invention is directed to providing a monoclonal antibody having high selectivity and affinity for AGEs, particularly, AGEs derived from glyceraldehyde or AGEs derived from glycolaldehyde, and an analysis method utilizing the same. Another object of the present invention is to provide methods for diagnosing, treating and preventing a disease using the monoclonal antibody.
Claims2
A compound represented by formula (I) or (II):
- wherein R1, R2, R3 and R4 are each independently selected from a hydrogen atom, a protecting group, and a peptide group having 1 to 1000 amino acid residues,
- X1 and X2 represent —O— or —NH—;
- Y1 and Y2 are a hydrogen atom, a protecting group, or a group:
- R5 and R6 are each independently selected from a hydrogen atom, a protecting group, and a peptide group having 1 to 1000 amino acid residues;
- or a cationic radical thereof, or a dication thereof or a salt thereof.
2 more elements
A method for preparing an antibody, which comprises:
- 1) reacting lysine in which an amino group at α-position is protected and glyceraldehyde to obtain a reaction mixture;
- 2) fractionating the reaction mixture to obtain a fraction containing a compound represented by formula (Ia), (Ib), (IIa), or (IIb):
- wherein R1, R3, and R6 are protecting groups
- 3) immunizing an animal using the fraction as an antigen to obtain an antibody.
1 more element
Dependencies are inferred from the claim text.